|
1
|
Monclair T, Brodeur GM, Ambros PF, Brisse
HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK,
Nuchtern JG, et al: INRG Task Force: The International
Neuroblastoma Risk Group (INRG) staging system: An INRG Task Force
report. J Clin Oncol. 27:298–303. 2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Naranjo A, Irwin MS, Hogarty MD, Cohn SL,
Park JR and London WB: Statistical Framework in Support of a
Revised Children's Oncology Group Neuroblastoma Risk Classification
System. JCO Clin Cancer Inform. 2:1–15. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Schwab M, Alitalo K, Klempnauer KH, Varmus
HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M and Trent J:
Amplified DNA with limited homology to myc cellular oncogene is
shared by human neuroblastoma cell lines and a neuroblastoma
tumour. Nature. 305:245–248. 1983.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Rovigatti U: Cancer modelling in the NGS
era - Part I: Emerging technology and initial modelling. Crit Rev
Oncol Hematol. 96:274–307. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Brodeur GM, Seeger RC, Schwab M, Varmus HE
and Bishop JM: Amplification of N-myc in untreated human
neuroblastomas correlates with advanced disease stage. Science.
224:1121–1124. 1984.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Matthay KK, Maris JM, Schleiermacher G,
Nakagawara A, Mackall CL, Diller L and Weiss WA: Neuroblastoma. Nat
Rev Dis Primers. 2(16078)2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mossé YP, Laudenslager M, Longo L, Cole
KA, Wood A, Attiyeh EF, Laquaglia MJ, Sennett R, Lynch JE, Perri P,
et al: Identification of ALK as a major familial neuroblastoma
predisposition gene. Nature. 455:930–935. 2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rovigatti U: Chronic Fatigue Syndrome
(CFS) and Cancer Related Fatigue (CRF): Two ‘fatigue’ syndromes
with overlapping symptoms and possibly related aetiologies.
Neuromuscul Disord. 22 (Suppl 3):S235–S241. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tomasetti C and Vogelstein B: Cancer
etiology. Variation in cancer risk among tissues can be explained
by the number of stem cell divisions. Science. 347:78–81.
2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rovigatti U: The Long Journey of cancer
Modeling: Ubi Sumus? Quo Vadimus? Mathew J Cancer Sci. 1:1–5.
2016.
|
|
11
|
Thiele CJ, Reynolds CP and Israel MA:
Decreased expression of N-myc precedes retinoic acid-induced
morphological differentiation of human neuroblastoma. Nature.
313:404–406. 1985.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Ross RA, Biedler JL and Spengler BA: A
role for distinct cell types in determining malignancy in human
neuroblastoma cell lines and tumors. Cancer Lett. 197:35–39.
2003.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rovigatti U: Isolation and initial
characterization of a new virus: Micro-Foci inducing virus or MFV.
C R Acad Sci III. 315:195–202. 1992.PubMed/NCBI
|
|
14
|
Furlan A, Dyachuk V, Kastriti ME,
Calvo-Enrique L, Abdo H, Hadjab S, Chontorotzea T, Akkuratova N,
Usoskin D, Kamenev D, et al: Multipotent peripheral glial cells
generate neuroendocrine cells of the adrenal medulla. Science.
357(eaal3753)2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
van Groningen T, Koster J, Valentijn LJ,
Zwijnenburg DA, Akogul N, Hasselt NE, Broekmans M, Haneveld F,
Nowakowska NE, Bras J, et al: Neuroblastoma is composed of two
super-enhancer-associated differentiation states. Nat Genet.
49:1261–1266. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rovigatti U: The glycosphingolipid GD2 as
an effective but enigmatic target of passive immunotherapy in
children with aggressive neuroblastoma (HR-NBL). Cancer Lett.
503:220–230. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Fletcher JI, Ziegler DS, Trahair TN,
Marshall GM, Haber M and Norris MD: Too many targets, not enough
patients: Rethinking neuroblastoma clinical trials. Nat Rev Cancer.
18:389–400. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Eleveld TF, Oldridge DA, Bernard V, Koster
J, Colmet Daage L, Diskin SJ, Schild L, Bentahar NB, Bellini A,
Chicard M, et al: Relapsed neuroblastomas show frequent RAS-MAPK
pathway mutations. Nat Genet. 47:864–871. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gatenby RA, Gillies RJ and Brown JS: Of
cancer and cave fish. Nat Rev Cancer. 11:237–238. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Muirhead CR, Tweddle DA, Basta NO and
McNally RJ: Temporal clustering of neuroblastic tumours in children
and young adults from Northern England. Environ Health.
14(72)2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Heath CW Jr: Community clusters of
childhood leukemia and lymphoma: Evidence of infection? Am J
Epidemiol. 162:817–822. 2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kinlen L: Childhood leukaemia, nuclear
sites, and population mixing. Br J Cancer. 104:12–18.
2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Greaves M: Infection, immune responses and
the aetiology of childhood leukaemia. Nat Rev Cancer. 6:193–203.
2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Vega-Lopez GA, Cerrizuela S, Tribulo C and
Aybar MJ: Neurocristopathies: New insights 150 years after the
neural crest discovery. Dev Biol. 444 (Suppl 1):S110–S143.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Pule MA, Savoldo B, Myers GD, Rossig C,
Russell HV, Dotti G, Huls MH, Liu E, Gee AP, Mei Z, et al:
Virus-specific T cells engineered to coexpress tumor-specific
receptors: Persistence and antitumor activity in individuals with
neuroblastoma. Nat Med. 14:1264–1270. 2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Flaegstad T, Andresen PA, Johnsen JI,
Asomani SK, Jørgensen GE, Vignarajan S, Kjuul A, Kogner P and
Traavik T: A possible contributory role of BK virus infection in
neuroblastoma development. Cancer Res. 59:1160–1163.
1999.PubMed/NCBI
|
|
27
|
Giraud G, Ramqvist T, Pastrana DV, Pavot
V, Lindau C, Kogner P, Orrego A, Buck CB, Allander T, Holm S, et
al: DNA from KI, WU and Merkel cell polyomaviruses is not detected
in childhood central nervous system tumours or neuroblastomas. PLoS
One. 4(e8239)2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mazar J, Li Y, Rosado A, Phelan P,
Kedarinath K, Parks GD, Alexander KA and Westmoreland TJ: Zika
virus as an oncolytic treatment of human neuroblastoma cells
requires CD24. PLoS One. 13(e0200358)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Rey F, Schwartz O and Wain-Hobson S:
Gain-of-function research: Unknown risks. Science. 342:311.
2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Rovigatti U, Tam A, Piccin A, Colognato R
and Sordat B: Preliminary Characterization of a New Type of Viruses
Isolated from Paediatric Neuroblastoma and Non-Hodgkin's Lymphoma:
potential Implications for Aetiology. In: Proceedings of the
International Conference on Childhood Leukaemia, London, section
P1-18, ppI-IV, 2004.
|
|
31
|
D'Angio GJ, Evans AE and Koop CE: Special
pattern of widespread neuroblastoma with a favourable prognosis.
Lancet. 1:1046–1049. 1971.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yu AL, Gilman AL, Ozkaynak MF, London WB,
Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay
KK, et al: Children's Oncology Group: Anti-GD2 antibody with
GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J
Med. 363:1324–1334. 2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kushner BH, LaQuaglia MP, Modak S, Wolden
SL, Basu EM, Roberts SS, Kramer K, Yataghene K, Cheung IY and
Cheung NV: MYCN-amplified stage 2/3 neuroblastoma: Excellent
survival in the era of anti-GD2 immunotherapy. Oncotarget.
8:95293–95302. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Molenaar JJ, Koster J, Zwijnenburg DA, van
Sluis P, Valentijn LJ, van der Ploeg I, Hamdi M, van Nes J,
Westerman BA, van Arkel J, et al: Sequencing of neuroblastoma
identifies chromothripsis and defects in neuritogenesis genes.
Nature. 483:589–593. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
zur Hausen H: Papillomaviruses in the
causation of human cancers - a brief historical account. Virology.
384:260–265. 2009.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Haars R, Zentgraf H, Gateff E and Bautz
FA: Evidence for endogenous reovirus-like particles in a tissue
culture cell line from Drosophila melanogaster. Virology.
101:124–130. 1980.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bell TM, Massie A, Ross MG, Simpson DI and
Griffin E: Further isolations of reovirus type 3 from cases of
Burkitt's lymphoma. BMJ. 1:1514–1517. 1966.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kinzler KW and Vogelstein B:
Cancer-susceptibility genes. Gatekeepers and caretakers. Nature.
386:761–763, 763. 1997.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sottoriva A, Kang H, Ma Z, Graham TA,
Salomon MP, Zhao J, Marjoram P, Siegmund K, Press MF, Shibata D, et
al: A Big Bang model of human colorectal tumor growth. Nat Genet.
47:209–216. 2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Fojo T: Novel_target.com. Oncologist.
6:313–314. 2001.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer Genome Landscapes.
Science. 339:1546–1558. 2013.PubMed/NCBI View Article : Google Scholar
|
